# Clinical Study of Compound Ciwujia Granules in the Treatment of Depression

> **NCT07085143** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Mental Health Center** · enrollment: 60 (estimated)

## Conditions studied

- Depression - Major Depressive Disorder
- Depression Disorders

## Interventions

- **DRUG:** Compound Ciwujia Granules
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT07085143
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-06-20
- **Final completion:** 2026-07-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- Heilongjiang Quanle Pharmaceutical Co., Ltd.

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07085143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07085143, "Clinical Study of Compound Ciwujia Granules in the Treatment of Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07085143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*